Skip to content

PHARMACIE VANHEES: what changed

BE 0506.907.647NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€36,252
2024 · €38,075-€1,823
Equity
€170,861
2024 · €134,609+€36,252
Cash
€148,213
2024 · €123,955+€24,258
Balance sheet total
€346,872
2024 · €304,712+€42,160

Largest movements

2024 to 2025
Assets
  • Cash +€24,258

    up €24,258 (+19.6%), from €123,955 to €148,213

    mainly Net result for the year (+€36,252) and Trade debts (+€34,221)

  • Receivables within one year +€17,564

    up €17,564 (+33.2%), from €52,935 to €70,498

    of which Trade receivables: +€19,297

Equity and liabilities
  • Profit (loss) carried forward +€36,252

    up €36,252 (+30.1%), from €120,349 to €156,601

  • Trade debts +€34,221

    up €34,221 (+26.5%), from €128,910 to €163,130

  • Other debts -€15,648

    no longer reported in 2025; in 2024 it stood at €15,648

  • Current portion of long-term debt -€10,693

    down €10,693 (-83.1%), from €12,869 to €2,176

Income statement
  • Gross operating margin -€3,148

    down €3,148 (-2.2%), from €142,348 to €139,200

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €38,075
Gross operating margin -€3,148
Staff costs +€235
Depreciation +€443
Other operating charges -€242
Other operating items +€321
Financial charges -€135
Taxes +€703
Result 2025 €36,252
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€37,127
Investment €0
Financing -€12,869
Cash 2024 €123,955
Net result for the year +€36,252
Depreciation +€1,487
Stocks and contracts -€2,164
Receivables within one year -€17,564
Deferred charges and accrued income +€339
Trade debts +€34,221
Tax, wage and social debts +€180
Other debts -€15,648
Accrued charges and deferred income +€25
Debts after one year -€2,176
Current portion of long-term debt -€10,693
Cash 2025 €148,213
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €304,712 €346,872 +€42,160 +13.8%
Fixed assets 21/28 €4,839 €3,353 -€1,487 -30.7%
Tangible fixed assets 22/27 €4,839 €3,353 -€1,487 -30.7%
Plant, machinery and equipment 23 €4,839 €3,353 -€1,487 -30.7%
Current assets 29/58 €299,873 €343,519 +€43,647 +14.6%
Stocks and contracts in progress 3 €120,464 €122,628 +€2,164 +1.8%
Stocks 30/36 €120,464 €122,628 +€2,164 +1.8%
Amounts receivable within one year 40/41 €52,935 €70,498 +€17,564 +33.2%
Trade receivables 40 €41,790 €61,087 +€19,297 +46.2%
Other amounts receivable 41 €11,145 €9,412 -€1,733 -15.6%
Cash at bank and in hand 54/58 €123,955 €148,213 +€24,258 +19.6%
Deferred charges and accrued income 490/1 €2,519 €2,180 -€339 -13.5%
Total equity and liabilities 10/49 €304,712 €346,872 +€42,160 +13.8%
Equity 10/15 €134,609 €170,861 +€36,252 +26.9%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Distributable reserves 133 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €120,349 €156,601 +€36,252 +30.1%
Amounts payable 17/49 €170,103 €176,011 +€5,908 +3.5%
Amounts payable after more than one year 17 €2,176 - -€2,176
Financial debts 170/4 €2,176 - -€2,176
Amounts payable within one year 42/48 €167,927 €175,987 +€8,060 +4.8%
Current portion of amounts payable after more than one year 42 €12,869 €2,176 -€10,693 -83.1%
Trade debts 44 €128,910 €163,130 +€34,221 +26.5%
Suppliers 440/4 €128,910 €163,130 +€34,221 +26.5%
Taxes, remuneration and social security 45 €10,500 €10,681 +€180 +1.7%
Remuneration and social security 454/9 €10,500 €10,681 +€180 +1.7%
Other amounts payable 47/48 €15,648 - -€15,648
Accrued charges and deferred income 492/3 - €25 +€25
Remuneration, social security and pensions 62 €86,538 €86,303 -€235 -0.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,929 €1,487 -€443 -22.9%
Other operating charges 640/8 €20 €262 +€242 +1,242%
Non-recurring operating charges 66A €321 - -€321
Gross operating margin 9900 €142,348 €139,200 -€3,148 -2.2%
Operating profit (loss) 9901 €53,540 €51,149 -€2,391 -4.5%
Financial charges 65/66B €1,602 €1,737 +€135 +8.4%
Recurring financial charges 65 €1,602 €1,737 +€135 +8.4%
Profit (loss) for the period before taxes 9903 €51,939 €49,412 -€2,526 -4.9%
Income taxes 67/77 €13,864 €13,161 -€703 -5.1%
Profit (loss) for the period 9904 €38,075 €36,252 -€1,823 -4.8%
Profit (loss) for the period to be appropriated 9905 €38,075 €36,252 -€1,823 -4.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€239,202 to €300,710

Midpoint €264,830 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €170,861
Capitalised earnings €307,543 to €430,560
Indication €239,202 to €300,710

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€170,861
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€170,861

Capitalised earnings

net result for the year (9904)
2025
€36,252
2024
€38,075
excluding non-recurring income and charges
€38,396
2023
€54,521
2022
€56,261
2021
€33,909
Average result, excluding non-recurring income and charges
€43,056
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€307,543 / €358,800 / €430,560

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.